Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Implantable Cardioverter Defibrillators (ICDs) Market from 2024 to 2025?

The market for implantable cardioverter defibrillators (ICDs) has seen significant growth in the past years. It is projected to expand from $3.76 billion in 2024 to $3.99 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.0%. This growth during the historic period is due to several factors such as the increasing cases of sudden cardiac arrest, the use of ICDs in preventing secondary sudden cardiac arrest, heightened public consciousness, a growing elderly population, supportive government and healthcare organisation policies, and improved healthcare accessibility.

What Is the Projected Market Size of the Implantable Cardioverter Defibrillators (ICDs) Market?

The market for implantable cardioverter defibrillators (ICDs) is predicted to experience robust growth in the upcoming years, expanding to $4.99 billion by 2029 with a compound annual growth rate (CAGR) of 5.8%. This growth during the projected period is linked to the increased acceptance of ICDs, higher demand for individualized cardiac care, the escalating occurrence of cardiac rhythm disorders, and a surge in demand in developing markets. Key trends expected throughout this period comprise technological improvements, the launch of subcutaneous ICDs which exclude transvenous leads, the desire for combined ICDs with pacemaker capabilities, enhancements in sensing and detection algorithms, ongoing progress in wireless charging and battery tech, and the incorporation of artificial intelligence (AI) in healthcare and data analytics.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20839&type=smp

Who are the Major Competitors in the Implantable Cardioverter Defibrillators (ICDs) Market Outlook?

Major companies operating in the implantable cardioverter defibrillators (ICDs) market are Abbott Laboratories, Medtronic Inc., Koninklijke Philips N.V., Boston Scientific Corporation, ZOLL Medical Corporation, St. Jude Medical Inc., BIOTRONIK SE & Co. KG, Nihon Kohden Corporation, Fukuda Denshi Co. Ltd., LivaNova PLC, MicroPort Scientific Corporation, Japan Lifeline Co. Ltd., AtriCure Inc., Physio-Control Inc., BPL Medical Technologies Private Limited, Kestra Medical Technologies Inc., CU Medical Germany GmbH, Metrax GmbH, Intermedics Inc., Sorin Group S.p.A.

What Is Fueling Growth in the Implantable Cardioverter Defibrillators (ICDs) Market?

The surge in cardiovascular diseases (CVDs) is anticipated to augment the expansion of the implantable cardioverter defibrillators (ICDs) market in the future. CVDs encompass a variety of disorders that plague the heart and blood vessels, including heart attacks, strokes, and hypertension. These disorders often result from unhealthy dietary habits, sedentary lifestyles, smoking, and genetics. The mounting prevalence of CVDs is largely as a result of aging demographic trends, detrimental lifestyle choices, and increasing instances of risk factors such as obesity, diabetes, and hypertension. Implantable cardioverter defibrillators (ICDs) aid in the management of CVDs by delivering potentially life-saving shocks to reestablish normal heart rhythms in patients prone to sudden cardiac arrest. For example, the Australian Institute of Health and Welfare, a government agency based in Australia, reported that in December 2023, deaths certified by doctors as caused by coronary heart disease (CHD) surged to 14,100 in 2021 and further escalated to 14,900 in 2022. Consequently, the growing prevalence of cardiovascular diseases (CVDs) is propelling the rise of the implantable cardioverter defibrillators (ICDs) market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20839&type=smp

Which Implantable Cardioverter Defibrillators (ICDs) Market Segments Are Growing the Fastest?

The implantable cardioverter defibrillators (ICDs) market covered in this report is segmented –

1) By Type: Single Chamber Implantable Cardioverter Defibrillators (ICDs), Dual Chamber Implantable Cardioverter Defibrillators (ICDs), Biventricular Devices

2) By Applications: Bradycardia, Tachycardia, Heart Failure, Other Applications

3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Single Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Single Chamber ICDs, MRI-Compatible Single Chamber ICDs, Wireless Single Chamber ICDs

2) By Dual Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Dual Chamber ICDs, MRI-Compatible Dual Chamber ICDs, Wireless Dual Chamber ICDs

3) By Biventricular Devices: CRT-D (Cardiac Resynchronization Therapy Defibrillator), CRT-P (Cardiac Resynchronization Therapy Pacemaker), Biventricular ICDs With Advanced Features (Remote Monitoring, Wireless Capabilities)

Which Industry Trends Are Shaping the Future of the Implantable Cardioverter Defibrillators (ICDs) Market?

Key players in the implantable cardioverter defibrillators (ICDs) market are prioritizing technological enhancements such as defibrillators that consume less power to boost device performance, increase battery longevity, and augment patient comfort. Defibrillators with low current consumption are engineered to distribute electric shocks to the heart, utilizing less energy. This not only extends battery life but also ensures effective arrhythmia treatment. MicroPort CRM, a French medical gadget firm, introduced the ULYS implantable cardioverter defibrillator (ICD) and the INVICTA defibrillation lead in Japan in October 2023, signifying a remarkable progression in cardiac care technology. These instruments have novel features like low power use for extended battery life and MRI compatibility, making them suitable for patients requiring imaging procedures. Furthermore, the ULYS ICD incorporates the PARAD+ arrhythmia discrimination algorithm and AutoMRI capability, heightening patient safety during MRI scans. Beyond this, the INVICTA lead demonstrated a 100% success rate in implantations and a 97.4% complication-free rate in clinical tests, underscoring its dependability and efficacy.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/implantable-cardioverter-defibrillators-icds-global-market-report

Which Countries Are Leading the Implantable Cardioverter Defibrillators (ICDs) Market?

North America was the largest region in the implantable cardioverter defibrillators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardioverter defibrillators (ICDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20839

This Report Delivers Insight On:

1. How big is the implantable cardioverter defibrillators (icds) market, and how is it changing globally?

2. Who are the major companies in the implantable cardioverter defibrillators (icds) market, and how are they performing?

3. What are the key opportunities and risks in the implantable cardioverter defibrillators (icds) market right now?

4. Which products or customer segments are growing the most in the implantable cardioverter defibrillators (icds) market?

5. What factors are helping or slowing down the growth of the implantable cardioverter defibrillators (icds) market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model